VBI Vaccines (VBIV) Earnings Date, Estimates & Call Transcripts $0.71 +0.02 (+2.90%) (As of 12/8/2023 ET) Add Compare Share Share Today's Range$0.69▼$0.7250-Day Range$0.50▼$0.7152-Week Range$0.45▼$21.00Volume70,369 shsAverage Volume156,659 shsMarket Capitalization$16.82 millionP/E RatioN/ADividend YieldN/APrice TargetN/A EarningsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMar. 11EstimatedActual EPS (Nov. 14) -$0.38 Missed By -$0.24 Consensus EPS (Nov. 14) -$0.14 Get VBI Vaccines Earnings AlertsEnter your email address below to receive the latest news and earnings results for VBIV and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueVBIV Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VBIV Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. VBI Vaccines Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20232($0.08)($0.07)($0.08)Q2 20232($0.07)($0.07)($0.07)Q3 20232($0.07)($0.07)($0.07)Q4 20232($0.07)($0.06)($0.07)FY 20238($0.29)($0.27)($0.28)VBIV Earnings Date and InformationVBI Vaccines last posted its earnings results on November 14th, 2023. The biopharmaceutical company reported ($0.38) EPS for the quarter, missing analysts' consensus estimates of ($0.14) by $0.24. The company earned $6.62 million during the quarter, compared to analysts' expectations of $13.25 million. VBI Vaccines has generated ($11.68) earnings per share over the last year (($11.68) diluted earnings per share). Earnings for VBI Vaccines are expected to grow in the coming year, from ($2.16) to ($0.82) per share. VBI Vaccines has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 11th, 2024 based off prior year's report dates.Read More VBI Vaccines Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 3/11/2024Estimated)------- 11/14/2023Q3 2023($0.14)($0.38)($0.24)$0.25$13.25 million$6.62 million8/14/2023Q2 2023($2.16)($2.17)($0.01)$0.71$1.46 million$0.72 million5/15/2023Q1 2023($2.27)($2.43)($0.16)($1.64)$0.82 million$0.49 million3/13/2023Q4 2022($1.40)($1.60)($0.20)($0.08)$1.98 million$0.29 million11/10/2022Q3 2022($1.60)($1.80)($0.20)($0.08)$1.29 million$0.32 million8/8/2022Q2 2022($1.40)($3.60)($2.20)($0.18)$0.70 million$0.35 million Get the Latest News and Ratings for VBIV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VBI Vaccines and its competitors with MarketBeat's FREE daily newsletter. 5/9/2022Q1 2022($1.60)($1.60)-($0.08)$0.13 million$0.13 million3/7/2022Q4 2021($1.40)($1.40)-($0.07)$0.14 million$0.08 million11/8/2021Q3 2021($1.40)($1.20)+$0.20($0.06)$0.26 million$0.11 million8/1/2021Q2 2021($1.40)($1.40)-($0.07)$0.55 million$0.14 million5/10/2021Q1 2021($1.20)($1.40)($0.20)($0.07)$0.51 million$0.30 million3/1/2021Q4 2020($1.20)($1.20)-($0.06)$0.44 million$0.16 million VBI Vaccines Earnings - Frequently Asked Questions When is VBI Vaccines's earnings date? VBI Vaccines has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 11th, 2024 based off last year's report dates. Learn more on VBIV's earnings history. Did VBI Vaccines beat their earnings estimates last quarter? In the previous quarter, VBI Vaccines (NASDAQ:VBIV) missed the analysts' consensus estimate of ($0.14) by $0.24 with a reported earnings per share (EPS) of ($0.38). Learn more on analysts' earnings estimate vs. VBIV's actual earnings. How much revenue does VBI Vaccines generate each year? VBI Vaccines (NASDAQ:VBIV) has a recorded annual revenue of $8.12 million. How much profit does VBI Vaccines generate each year? VBI Vaccines (NASDAQ:VBIV) has a recorded net income of -$113.30 million. VBIV has generated -$11.68 earnings per share over the last four quarters. What is VBI Vaccines's EPS forecast for next year? VBI Vaccines's earnings are expected to grow from ($2.16) per share to ($0.82) per share in the next year. More Earnings Resources from MarketBeat Related Companies: ONTX Earnings Date IMPL Earnings Date ORGS Earnings Date LABP Earnings Date AGE Earnings Date APRE Earnings Date VINC Earnings Date NNVC Earnings Date GNPX Earnings Date TCRT Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Diamondback Energy: 7x earnings is an energy diamond in the roughSamsara's big rally: 27% surge following stellar Q3 earningsThe truth about Lululemon earnings: Suddenly in bearish crosshairOwn Dollar General? Hurry and take this advice before earningsEarnings propel Crowdstrike, cybersecurity sector, to new highsAlibaba is down more than 10% since earnings, now what?2 stocks that faded their price gaps after crushing earnings This page (NASDAQ:VBIV) was last updated on 12/9/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VBI Vaccines Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.